Related Experiment Video
Updated: May 11, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Heat shock protein 70 levels in children with nephrotic syndrome
Bağdagül Aksu1, Zeynep Nagehan Yürük Yıldırım2, Asuman Gedikbaşı1
1Department of Pediatric Basic Sciences, Institute of Child Health, İstanbul University, İstanbul, Türkiye.
Insights
Urine heat shock protein 70 (uHSP70) levels are elevated in children with steroid-sensitive nephrotic syndrome (SSNS) before treatment and decrease with prednisolone therapy, indicating reduced renal stress. uHSP70 may serve as a biomarker for monitoring treatment response.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Glomerular Diseases
Background:
- Idiopathic nephrotic syndrome (NS) is a common glomerular disease in children.
- Heat shock protein 70 (HSP70) responds to cellular stress, including infections and oxidative stress.
- Investigating HSP70 in steroid-sensitive nephrotic syndrome (SSNS) can offer insights into disease mechanisms and treatment response.
Purpose of the Study:
- To evaluate serum and urine HSP70 levels in children with SSNS.
- To assess changes in HSP70 levels during prednisolone treatment.
- To determine if HSP70 levels can differentiate between frequently and infrequently relapsing SSNS.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum and urine HSP70 levels.
- Samples were collected from 36 SSNS patients and 35 healthy children at four time points: before treatment and on days 15, 30, and 90.
- HSP70 levels were analyzed in relation to treatment status and relapse frequency.
Main Results:
- Pre-treatment urine HSP70 (uHSP70) and uHSP70/creatinine ratios were significantly higher in SSNS patients compared to controls (p<0.0001).
- Serum HSP70 (sHSP70) levels were lower in SSNS patients before treatment (p=0.002).
- uHSP70 levels significantly decreased during prednisolone treatment (p<0.0001), while no significant differences in HSP70 levels were observed between frequent and infrequent relapsers.
Conclusions:
- Elevated uHSP70 in SSNS patients before treatment suggests renal stress and damage.
- Decreasing uHSP70 levels with prednisolone therapy indicate reduced renal stress and effective treatment.
- uHSP70 shows potential as a biomarker for monitoring renal damage and treatment response in SSNS, but does not differentiate relapse frequency.
Background:
Idiopathic nephrotic syndrome (NS) is the most prevalent glomerular disease in children. Heat shock protein 70 (HSP70) is synthesized in response to diverse stress factors like infections and oxidative stress. We aimed to evaluate serum and urine levels of HSP70 in children with steroid-sensitive nephrotic syndrome (SSNS) and to assess changes in HSP70 levels with prednisolone treatment. Additionally, we seek to determine whether serum and urine levels of HSP70 can differentiate between frequently relapsing and infrequently relapsing cases in children with SSNS.
Methods:
A total of 36 patients with SSNS and 35 healthy children were included in the study. Samples were taken from all patients at four time points; before corticosteroid treatment (day 0) and on days 15, 30, and 90 after the initiation of corticosteroid treatment. Serum and urine levels of HSP70 were measured by enzyme-linked immunosorbent assay (ELISA).
Results:
In the NS group before steroid treatment (day 0), urine HSP70 (uHSP70) levels and urine HSP70/creatinine (uHSP70/Cre) ratios were significantly higher (p<0.0001), whereas serum HSP70 (sHSP70) levels were lower (p=0.002), compared to the healthy group. uHSP70 levels decreased gradually during prednisolone treatment in the patient group (p<0.0001). There was no difference in terms of sHSP70, uHSP70, and uHSP70/Cre ratios between patients with frequently relapsing and infrequently relapsing.
Conclusions:
Our study demonstrates that uHSP70 levels are elevated in SSNS prior to treatment and decrease with prednisolone therapy, reflecting reduced renal stress and damage. uHSP70 may be a useful biomarker for monitoring renal damage and treatment response. Serum and urine levels of HSP70, as well as uHSP70/Cre ratios, did not differentiate between frequent and infrequent relapses.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Serum Studies: Renal Function Tests
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

